2.85
price up icon1.79%   0.05
after-market Dopo l'orario di chiusura: 2.85
loading

Galectin Therapeutics Inc Azioni (GALT) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
0.91%
9.648
9.561 9.166 9.003 10.34
Interest Income/Expense
24.20%
1.052
0.847 0.835 0.65 0.46
Operating Income/Loss
0.91%
-9.648
-9.561 -9.166 -9.003 -10.34
Nonoperating Income/Loss
322.25%
-1.841
-0.436 -1.262 -0.111 -1.185
Income/Loss From Continuing Operations Before Tax
14.92%
-11.49
-9.997 -10.43 -9.114 -11.53
Income/Loss From Continuing Operations After Tax
14.92%
-11.49
-9.997 -10.43 -9.114 -11.53
Net Income/Loss
14.92%
-11.49
-9.997 -10.43 -9.114 -11.53
Preferred Stock Dividends And Other Adjustments
87.30%
0.008
0.063 -0.006 0.063 -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10,792%
61.98
0.569 59.70 59.58 59.48
Diluted Average Shares
10,792%
61.98
0.569 59.70 59.58 59.48
Basic Earnings Per Share
18.75%
-0.19
-0.16 -0.24 -0.15 -0.19
Diluted Earnings Per Share
18.75%
-0.19
-0.16 -0.24 -0.15 -0.19
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
87.30%
0.008
0.063 -0.006 0.063 -
$21.87
price up icon 3.40%
$35.60
price down icon 2.49%
$104.59
price up icon 1.67%
$28.27
price up icon 16.05%
$112.49
price up icon 1.66%
biotechnology ONC
$279.16
price up icon 3.51%
Capitalizzazione:     |  Volume (24 ore):